Oppenheimer units $12 goal on SAB Biotherapeutics shares By Investing.com
On Tuesday, Oppenheimer initiated protection on SAB Biotherapeutics (NASDAQ:SABS) with an Outperform…
Backblaze shares goal lowered by Oppenheimer, market pressures cited By Investing.com
On Friday, Oppenheimer adjusted its outlook on Backblaze Inc (NASDAQ:BLZE) shares, decreasing…
